Quantum Pharmaceutical appoints commercial director

Victoria Buyer has 10 years of industry experience

Quantum Pharmaceutical, a UK-based pharmaceutical specials manufacturer, has appointed Victoria Buyer as commercial director.

With a decade’s industry experience, Buyer has previously been responsible for the growth and development of companies including GlaxoSmithKline and Alliance UniChem.

Buyer said: ‘Quantum already strives to ensure its operations are at the forefront of the marketplace – and I’m determined to build on its strong foundations and forge links with new partners while reinforcing collaboration with our loyal customer network.’

You may also like

Containment
Quantum Pharmaceutical opens aseptic manufacturing facility

Quantum Pharmaceutical opens aseptic manufacturing facility

Incorporates aseptic compounding and manufacturing services, including gassing isolators
Manufacturing
Quantum Pharmaceutical moves into new HQ

Quantum Pharmaceutical moves into new HQ

Opens up potential for further expansion of the UK specials manufacturer
Research & Development
Norstella launches Atlas, an agentic AI platform built on biopharma's most connected data

Norstella launches Atlas, an agentic AI platform built on biopharma's most connected data

New platform combines Norstella's proprietary data assets with purpose-built AI agents to deliverdecision-ready outputs across the drug development lifecycle
Drug Delivery
Fridge-free tetanus-diphtheria vaccine passes first human trial

Fridge-free tetanus-diphtheria vaccine passes first human trial

Stablepharma's SPVX02 vaccine remains stable at 30°C for two years, new Phase I data shows, easing cold-chain dependence
Manufacturing
Edwards cryogenic portfolio now available globally

Edwards cryogenic portfolio now available globally

Bringing cryogenic cooling and vacuum technologies together in one integrated portfolio for customers worldwide
Manufacturing
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs

SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs

Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Portable gas detection in the pharmaceutical sector

Portable gas detection in the pharmaceutical sector

Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
Subscribe now